Advanced search
Publication Cover
Leukemia & Lymphoma Volume 44, 2003 - Issue 8
Submit an article Journal homepage
44
Views
3
CrossRef citations to date
0
Altmetric
Research Article

Treatment of Advanced Hodgkin's Disease: EBVD versus Intensive Brief Chemotherapy

Agustin Avilés Oncology Research Unit, Oncology Hospital National Medical Center, IMSS México, D.F. Mexico
,
Sergio Cleto Department of Hematology, Oncology Hospital National Medical Center, IMSS México, D.F. Mexico
,
Natividad Neri Department of Hematology, Oncology Hospital National Medical Center, IMSS México, D.F. Mexico
,
Judith Huerta-Guzmán Department of Hematology, Oncology Hospital National Medical Center, IMSS México, D.F. Mexico
,
Alejandra Talavera Department of Hematology, Oncology Hospital National Medical Center, IMSS México, D.F. Mexico
,
Claudia Castañeda Department of Hematology, Oncology Hospital National Medical Center, IMSS México, D.F. Mexico
&
Martha González Department of Hematology, Oncology Hospital National Medical Center, IMSS México, D.F. Mexico
 show all
Pages 1361-1365 | Published online: 01 Jul 2009

References

  • Aisenberg, A. (1999) "Problems in Hodgkin's management", Blood 76, 761 —779.
  • Engert, A., Wolf, A. and Diehl, V. (1999) "Treatment of advanced Hodgkin's lymphomas. Standard and experimental approaches", Semin. Hematol. 36, 282–289.
  • Aviles, A., Neri, N., Cuadra, I., Alvarado, I. and Cleto, S. (2000) "Second letal events associated with treatment for Hodgkin's disease. A review of 2980 patients treated in a single Mexican Institute", Leuk. Lymphoma 39, 311–319.
  • Aviles, A., Arévila, N., Diaz-Maqueo, J.C., Gómez, T., Garcia, R. and Nambo, M.J. (1993) "Late cardiac toxicity of doxorubicin, epirubicin and mitoxantrone therapy for Hodgkin's disease in adults", Leuk. Lymphoma 11, 275–279.
  • Aviles, A., Guzman, R., Talavera, A., Garcia, E.L. and Diaz-Maqueo, J.C. (1994) "Randomized study for the treatment of adult advanced Hodgkin's disease: epirubicin, vinblastine, bleomycin and dacarbazine (EBVD) versus mitoxantrone, vinblas-tine, bleomycin and dacarbazine (MVBD)", Med. Pediatr. Oncol. 22, 168–172.
  • Aviles, A., Soto, B., Guzman, R., Garcia, E.L., Nambo, M.J. and Diaz-Maqueo, J.C. (1995) "Results of a randomized study of early stage Hodgkin's disease using ABVD, EBVD or MBVD", Med. Pediatr Oncol. 24, 171–175.
  • Hagemeister, F.B., Cabanillas, F., Velasquez, W., et al. (1990) "NOW: a novel chemotherapeutic regimen with minimal toxicity for treatment of Hodgkin's disease", Semin. Oncol. 17\(Suppl. 10), 34–40.
  • Hoerni, B., Orgerie, MB., Bali, E.G.H., et al. (1988) "Nouvelle association d'epirubicine, bleomycine, vinblastine et prednisone (EBVP) avant radiotherapie clans les stades localized de maladie de Hodgkin: Essay de phase 11 ches 50 malades", Bull. Cancer 75, 789–794.
  • Connors, J.M. and Klimo, P. (1987) "MOPP/ABV hybrid chemotherapy for advanced Hodgkin's disease", Semin. Hematol. 24 (Suppl. 1), 35–40.
  • Connors, J.M., Klimo, P., Adams, S., et al. (1997) "Treatment of advanced Hodgkin's disease with chemotherapy. Comparison of MOPP/ABV hybrid regimen with alternating courses of MOPP and ABVD. A Report from the National Cancer Institute of Canada Clinical Trials Group", J. Clin. Oncol. 15, 1638–1641.
  • Viviani, S., Bonadonna, G., Santoro, A., et al. (1996) "Alternating versus hybrid MOPP and ABVD combination in advanced Hodgkin's disease. Ten years results", J. Clin. Oncol. 14, 1421–1430.
  • Somers, R., Carde, P., Henry-Amar, M., et al. (1994) "A randomized study in stage ILIB and IV Hodgkin's disease comparing eight courses of MOPP versus an alternation of MOPP and ABVD: a European Organization for Research and Treatment of Cancer Lymphoma Cooperative Group and Groupe Pierre—et-Marie-Curie controlled clinical trial", J. Clin. Oncol. 12, 279–287.
  • Klimo, P. and Connors, J.M. (1985) "MOPP/ABV hybrid program: combination chemotherapy based on early introduction of seven effective drugs for advanced Hodgkin's disease", J. Clin. Oncol. 3, 1174–1182.
  • Canellos, G.P., Anderson, J.R., Propert, K.J., et al. (1992) "Chemotherapy of advanced Hodgkin's disease with MOPP-ABVD or MOPP alternating with ABVD", N. Engl. J. Med. 327, 1478–1484.
  • Gobbi, P., Pieresca, C., Ghirardelli, Au., et al. (1998) "Long term results from MOPPEBVCAD chemotherapy with optimal limited radiotherapy in advanced Hodgkin's disease", Blood 91, 2704–2712.
  • Tesh, H., Diehl, V., Lathan, B., et al. (1998) "Moderate dose escalation for advanced stage Hodgkin's disease using the bleomycin, etoposide, adriamycin, cyclophosphamide, vincristine, procarbazine and prednisone scheme and adjuvant radiotherapy. A study of the German Hodgkin's Lymphoma Study Group", Blood 92, 4560–4567.
  • Horning, S.J., Rosenberg, S.A. and Hoppe, R.T. (1996) "Brief chemotherapy (Stanford V) and adjuvant radiotherapy for bulky and advanced Hodgkin's disease", Ann. Oncol. 7 (Suppl. 6), S105—S110.
  • Horning, S.J., Williams, J., Bartlet, NI., et al. (2000) "Assessment of the Stanford V regimen and consolidative radiotherapy for bulky and advanced Hodgkin's disease. Eastern Cooperative Oncology Group Pilot Study E 1492", J. Clin. Oncol. 18, 972–977.
  • Aviles, A., Delgado, S., Talavera, A., Gonzalez, J.L. and Diaz-Maqueo, J.C. (2000) "Adjuvant radiotherapy to initial bulky disease in patients with advanced stage Hodgkin's disease", Hematology 4, 479–485.
  • Aviles, A., Neri, N., Garcia, E.L., Talavera, A. and Diaz-Maqueo, J.C. (2001) "Treatment of refractory Hodgkin's disease with modified Stanford V regimen", Med. Oncol. 18, 261–267.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.